MYC and breast cancer: It has been reported that the MYC mRNA, protein level, and transcriptional activity can be inhibited by DNA-damaging drugs, such as topoisomerase II inhibitors, or by ionizing radiation in MCF-7 breast cancer cells [68,69,70].